Pacira BioSciences (PCRX) Interest Coverage Ratio (2010 - 2026)
Pacira BioSciences (PCRX) recorded quarterly Interest Coverage Ratio of 1.87 in Q1 2026, up 210.35% quarter-over-quarter from 0.6 in Q4 2025, and up 329.44% on a YoY basis from 0.43 in Q1 2025.
Pacira BioSciences (PCRX) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Pacira BioSciences' Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 1.87 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 329.44% year-over-year to 1.87; the TTM figure through Mar 2026 stood at 1.46 (up 130.67% YoY), while the FY2025 annual figure was 1.1, up 124.84% from the prior year.
- Interest Coverage Ratio was 1.87 for Q1 2026 at Pacira BioSciences, up from 0.6 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 10.32 in Q2 2023 to a low of 29.76 in Q3 2024.
- Historically, Interest Coverage Ratio has averaged 1.43 across 5 years, with a median of 1.87 in 2026.
- Biggest YoY gain for Interest Coverage Ratio was 1336.03% in 2024; the steepest drop was 681.66% in 2024.
- A 5-year view of Interest Coverage Ratio shows it stood at 0.9 in 2022, then soared by 1192.59% to 9.79 in 2023, then tumbled by 46.08% to 5.28 in 2024, then sank by 88.61% to 0.6 in 2025, then surged by 210.35% to 1.87 in 2026.
- The last three Interest Coverage Ratio figures came in at 1.87 (Q1 2026), 0.6 (Q4 2025), and 1.49 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.31 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.72 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Pacira BioSciences | 935.46 Mn | 733.28 Mn | 140.96 Mn | 1.87 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.87 |
| Dec 31, 2025 | 0.60 |
| Sep 30, 2025 | 1.49 |
| Jun 30, 2025 | 1.81 |
| Mar 31, 2025 | 0.43 |
| Dec 31, 2024 | 5.28 |
| Sep 30, 2024 | -29.76 |
| Jun 30, 2024 | 7.27 |
| Mar 31, 2024 | 3.98 |
| Dec 31, 2023 | 9.79 |
| Sep 30, 2023 | 5.12 |
| Jun 30, 2023 | 10.32 |
| Mar 31, 2023 | -0.32 |
| Dec 31, 2022 | -0.90 |
| Sep 30, 2022 | 2.16 |
| Jun 30, 2022 | 3.54 |
| Mar 31, 2022 | 1.70 |
| Dec 31, 2021 | 0.40 |
| Sep 30, 2021 | 4.29 |
| Jun 30, 2021 | 4.96 |